DENALI ADVISORS LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 117 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DENALI ADVISORS LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q2 2020$203,000
+23.8%
3,320
+14.5%
0.04%
+8.3%
Q1 2020$164,000
-1.8%
2,900
-1.4%
0.04%
+50.0%
Q4 2019$167,000
+8250.0%
2,941
+11211.5%
0.02%
Q2 2019$2,0000.0%260.0%0.00%
Q1 2019$2,000
-33.3%
26
-46.9%
0.00%
-100.0%
Q4 2018$3,000
-25.0%
49
-30.0%
0.00%0.0%
Q3 2018$4,000
+100.0%
70
+27.3%
0.00%
Q2 2018$2,0000.0%550.0%0.00%
Q1 2018$2,000
+100.0%
55
+150.0%
0.00%
Q4 2017$1,0000.0%22
-18.5%
0.00%
Q3 2015$1,000270.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q2 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 385,954$16,723,00010.02%
JW Asset Management, LLC 73,649$3,191,0003.40%
Elk Creek Partners, LLC 168,714$7,310,0000.43%
NORTHPOINTE CAPITAL LLC 80,710$3,497,0000.39%
Ativo Capital Management LLC 33,096$1,434,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 155,318$6,730,0000.26%
ISTHMUS PARTNERS, LLC 17,406$754,0000.20%
Matarin Capital Management, LLC 48,952$2,121,090,0000.16%
GLOBEFLEX CAPITAL L P 4,324$187,0000.05%
Summit Trail Advisors, LLC 6,797$295,0000.04%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders